{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 459986767
| IUPAC_name = butane-1,4-diyl dimethanesulfonate
| image = Busulfan.svg
| image2 = Busulfan3d.png
| width2 = 250

<!--Clinical data-->
| tradename = Myleran
| Drugs.com = {{drugs.com|monograph|busulfan}}
| MedlinePlus = a682248
| licence_EU = Busilvex
| licence_US = Busulfan
| pregnancy_AU =  
| pregnancy_US = D
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = 口服、注射

<!--Pharmacokinetic data-->
| bioavailability = 80%（口服）
| protein_bound = 32.4%
| metabolism = [[肝脏|肝代谢]]
| elimination_half-life = 2.5 hours
| excretion = ?

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 55-98-1
| ATC_prefix = L01
| ATC_suffix = AB01
| PubChem = 2478
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = APRD00664
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2384
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = G1LN9045DK
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00248
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 28901
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 820

<!--Chemical data-->
| C=6 | H=14 | O=6 | S=2 
| molecular_weight = 246.304 g/mol
| smiles = O=S(=O)(OCCCCOS(=O)(=O)C)C
| InChI = 1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
| InChIKey = COVZYZSDYWQREU-UHFFFAOYAO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = COVZYZSDYWQREU-UHFFFAOYSA-N
| synonyms = 1,4-butanediol dimethanesulfonate
}}

'''白消安'''（{{lang-en|'''Busulfan'''}}，商品名'''马利兰'''、'''白舒非'''）是一种从1959年开始使用的抗癌药。它是一种[[细胞周期|细胞周期]]非特异性[[烷化剂|烷化剂]]，属于烷基磺酸酯类型，化学结构全称是'''1,4-丁二醇二甲烷磺酸酯'''。

==历史==
白消安曾经是[[化学疗法|化学疗法]]治疗[[慢性粒细胞白血病|慢性粒细胞白血病]]（CML）的首选药物，直至其被特效药[[伊马替尼|伊马替尼]]取代。不过由于白消安的廉价，该药物仍被一定程度上地使用。

==适应症==
目前，白消安主要用于[[骨髓移植|骨髓移植]]，尤其是在慢性粒细胞白血病情况下被用作一种备用药物。它能够控制肿瘤负荷，但是不能够防止[[癌细胞|癌细胞]]变形或纠正细胞异常。白消安最近在一项研究中被用来探究[[血小板|血小板]]运送的[[血清素|血清素]]在[[肝脏|肝脏]]的自动修复中的角色。<ref>{{cite journal | author = Lesurtel M, Graf R, Aleil B, Walther D, Tian Y, Jochum W, Gachet C, Bader M, Clavien P | title = Platelet-derived serotonin mediates liver regeneration | journal = Science | volume = 312 | issue = 5770 | pages = 104–7 | year = 2006 | pmid = 16601191 | doi = 10.1126/science.1123842}}</ref>

==副作用==
毒性作用可能包括间断的[[肺纤维化|肺纤维化]]、{{link-en|色素沉着|Hyperpigmentation}}、[[癫痫发作|癫痫发作]]、{{link-en|肝静脉阻塞症|Hepatic veno-occlusive disease}}和[[惡病體質|惡病體質]]。白消安还能导致{{link-en|血小板减少|Thrombocytopenia}}。长期使用会导致[[骨髓抑制|骨髓抑制]]，甚至[[再生障碍性贫血|再生障碍性贫血]]。

[[苯妥英|苯妥英]]可以与白消安共用以预防癫痫发作。{{link-en|左乙拉西坦|Levetiracetam}}和[[苯二氮卓类药物|苯二氮卓类药物]]也对白消安引发的癫痫发作具有治疗效果。<ref name="Eberly-2008">{{Cite journal | last1 = Eberly | first1 = AL. | last2 = Anderson | first2 = GD. | last3 = Bubalo | first3 = JS. | last4 = McCune | first4 = JS. | title = Optimal prevention of seizures induced by high-dose busulfan. | url = https://archive.org/details/sim_pharmacotherapy_2008-12_28_12/page/1502 | journal = Pharmacotherapy | volume = 28 | issue = 12 | pages = 1502–10 | doi = 10.1592/phco.28.12.1502 | pmid = 19025431 |date=Dec 2008}}</ref>

白消安被[[国际癌症研究机构|国际癌症研究机构]]（IARC）列为[[1类致癌物|1类致癌物]]。

==作用機轉==

白消安的作用机制是通过[[DNA|DNA]]的烷基化，从而导致[[鸟嘌呤|鸟嘌呤]]-[[腺嘌呤|腺嘌呤]]的核酸链交联，<ref>{{cite journal |author=Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S |title=DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effect |journal=Cancer Sci. |volume=95 |issue=5 |pages=454–8 |pmid=15132775 |url=http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1347-9032&date=2004&volume=95&issue=5&spage=454 |doi=10.1111/j.1349-7006.2004.tb03231.x|date=May 2004}}</ref> 这个过程是通过[[双分子亲核取代反应|双分子亲核取代反应]]进行的<ref name=Foye>{{Cite book | author =Thomas L. Lemke, David A. Williams | title =Foye's Principles of Medicinal Chemistry | location = USA |chapter=Cancer and Chemotherapy| publisher = LWW| date = 2012 | pages = 1199-1226 | ISBN = 978-1609133450 | accessdate = 2017-05-29  | language = en }} </ref>，其中[[亲核体|亲核]]的鸟嘌呤的7位氮原子进攻甲磺酸[[离去基团|离去基团]]相邻的碳原子<ref name="Foye" />，如下圖上方所示。这种对DNA的损害无法被细胞所修复，因此导致癌细胞的[[细胞凋亡|凋亡]]。<ref>{{cite journal |author=Karstens A, Kramer I |title=Chemical and physical stability of diluted busulfan infusion solutions |journal=EJHP Science |volume=13 |pages=40–7 |year=2007 }}</ref>

另一項機轉為與[[半胱胺酸|半胱胺酸]]的[[硫醇|硫醇]][[官能基|官能基]]反應<ref name=MCAD>{{Cite book | author =Carmen Avendano, J. Carlos Menendez| title =Medicinal Chemistry of Anticancer Drug | location = USA |chapter=DNA alkylating agent| publisher = Elsevier Science | date = 2015 | pages = 197-237| ISBN = 978-0444626493 | accessdate = 2017-06-01  | language = en }} </ref>，如下圖下方[[File:_Busulfan_mechanism.svg|thumb]]

==络合反应==
有研究者用白消安进行的[[脲|脲]]基[[环糊精|环糊精]]的分子识别。<ref>{{cite journal | author = Menuel S, Joly JP, Courcot B, Elysee J, Ghermani NE, Marsura A | title = Synthesis and inclusion ability of a bis-beta-cyclodextrin pseudo-cryptand towards Busulfan anticancer agent | journal = Tetrahedron | volume = 63 | issue = 7 | pages = 1706–14 | year = 2007 |  doi = 10.1016/j.tet.2006.10.070}}</ref> 他们观察到了[[络合物|络合物]]通过脲基和白消安的磺酸酯部分之间的[[静电|静电]]作用而形成。

另外一种物质也用于构建白消安的络合物，这种物质的结构有两个[[二糖|二糖]]通过尿素连接的[[冠醚|冠醚]]。<ref>{{cite journal | author = Porwanski S, Florence DCB, Menuel S, Joly JP, Bulach V, Marsura A | title = Bis-beta-cyclodextrinyl- and bis-cellobiosyl-diazacrowns: synthesis and molecular complexation behaviors toward Busulfan anticancer agent and two basic aminoacids| journal = Tetrahedron | volume = 65 | issue = 31 | pages = 6196–6203| year = 2009 |  doi = 10.1016/j.tet.2009.05.057}}</ref>
==商品药物信息==
马利兰是薄膜包衣的[[片剂|片剂]]，每片含2毫克白消安。

==参考资料==
{{reflist}}

== 外部链接 ==
* [https://web.archive.org/web/20060409171749/http://us.gsk.com/products/assets/us_myleran.pdf 马利兰（英文）] 
* [https://web.archive.org/web/20070928230908/http://www.ivbusulfex.com/Busulfex_Marketing.Pi.8.06.pdf Busulfex（英文）] 
* [http://www.clinonc.com/content/drugdb/drug.cfm?DrugRef=552 详细资料（英文）] {{Wayback|url=http://www.clinonc.com/content/drugdb/drug.cfm?DrugRef=552 |date=20200330153031 }}

{{化疗药物}}

[[Category:甲磺酸酯|Category:甲磺酸酯]]
[[Category:IARC第1类致癌物质|Category:IARC第1类致癌物质]]
[[Category:烷基化抗肿瘤剂|Category:烷基化抗肿瘤剂]]
[[Category:罕用药|Category:罕用药]]